BRIEF published on 10/31/2025 at 18:05, 1 month 4 days ago 2025 Half-Year Results: Aton Confirms its Recovery Financial Recovery 2025 Results PIMS Technology Inoviem Scientific B Cell Design
BRIEF published on 10/08/2025 at 18:05, 1 month 27 days ago Strategic partnership between Inoviem Scientific and abc biopply in preclinical oncology Strategic Partnership 3D Models Therapeutic Innovation Preclinical Oncology Translational Pharmacology
BRIEF published on 09/29/2025 at 08:05, 2 months 6 days ago ATON Presents its New Strategy at the European MidCap Event 2025 Investors Governance Financial Strategy Aton European MidCap
BRIEF published on 09/17/2025 at 18:05, 2 months 17 days ago PIMS Technology secures €500,000 in funding from Bpifrance Funding Marketing Precision Medicine Bpifrance PIMS Technology
BRIEF published on 09/10/2025 at 18:10, 2 months 24 days ago Strategic partnership between Logical Biological and B Cell Design Public Health Strategic Partnership Technological Innovation Medical Diagnosis Monoclonal Antibodies
BRIEF published on 09/03/2025 at 18:05, 3 months 1 day ago ATON SA: New Phase of Valorization of its Technological Assets Financial Results Life Sciences Videoconferencing Technological Development ATON SA
BRIEF published on 04/30/2025 at 18:05, 7 months 4 days ago Financial Improvement for Aton in 2024 Financial Results Restructuring Future Development Aton Medical Societies
BRIEF published on 10/31/2024 at 18:05, 1 year 1 month ago Promising 2024 half-year results for Aton Sustainable Growth Cost Reduction Half-year Results Financial Restructuring Consolidation Of Assets
BRIEF published on 10/01/2024 at 18:35, 1 year 2 months ago Combined general meeting of September 30, 2024: Approval of the 2023 annual accounts and resolutions General Meeting Resolutions Financial Restructuring Aton Administrators
BRIEF published on 07/18/2024 at 18:05, 1 year 4 months ago Aton successfully finalizes its financial restructuring Treasury Financial Restructuring Increase In Capital Deleveraging Lock-up
Published on 12/05/2025 at 02:35, 10 hours 58 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 33 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 28 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 33 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 33 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 33 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 28 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 33 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 33 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 48 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 33 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 48 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 49 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
